New Mexico Drug and Alcohol Inpatient Treatment Licensing

Author: A. Ant, CADC-II, Licensing & Accreditation Expert

Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

Apply now: letter of intent by email to facility.license@hca.nm.gov (HCA facility licensing steps) | Questions: HCA Division of Health Improvement, Health Facility Licensing and Certification, facility.license@hca.nm.gov, Program Operations Bureau 505-476-9093

New Mexico wants to see a residential addiction program’s accreditation before it hands over a state license, which turns the usual order around. Under 8.321.13 NMAC, the letter of intent an applicant sends to the Health Care Authority (HCA), Division of Health Improvement (DHI) must list fifteen items, and the last two are “a behavioral health services division approval letter” and “the accreditation organization approval letter.” A program that was already running gets its license once the accreditor signs off, with no state Life Safety Code survey (8.321.13.11.D). The license is called the Adult Accredited Residential Treatment Center, or AARTC, and its rule took effect on May 19, 2026.

This guide covers adult residential substance use treatment and residential withdrawal management under that license, plus a short note on the special hospital route. Outpatient programs, office practices and stand-alone ketamine clinics are in New Mexico Drug and Alcohol Outpatient Treatment Licensing. Adult mental health residential care, which falls under the same AARTC license, is covered in New Mexico Mental Health Inpatient Licensing, and the agency map for the whole state is on New Mexico Behavioral Health Licensing.

From Accreditation Alone to a State License

Rule text here was read in the New Mexico Register and HCA’s posted copy of 8.321.13, and the statute in the official NMSA on nmonesource.com. The open question at the end is ours to raise, not DHI’s to have answered.

For years an adult residential program in New Mexico ran on two things: national accreditation and a certification from HCA’s Behavioral Health Services Division (BHSD). There was no state facility license behind them, a gap a handout to the Legislative Health and Human Services Committee pointed out in October 2025. DHI closed it with 8.321.13 NMAC, adopted in New Mexico Register Vol. XXXVII, Issue 10 and effective May 19, 2026. Its operating rule leaves no room: “No AARTC, or branch thereof, may operate in New Mexico without being duly licensed according to these regulations.” Residences that were already operating got a 90-day window to apply (8.321.13.20.B), and by our count that window closed on August 17, 2026.

The licensing office is also newer than a lot of operators realize. Facility licensing moved from the Department of Health to HCA on July 1, 2024 under 2024 SB 14 (Laws 2024, chapter 39), and the licensing statutes went with it into Chapter 24A of the NMSA, now titled the Health Care Code. Section 24A-1-5 reads: “A health facility shall not be operated without a license issued by the authority.” A policy manual or a lease rider that still names the Department of Health as the licensing body is out of date.

The rule does leave one thing unsettled. Its scope section describes “Agencies that receive state or federal funding for the purpose of providing one or more services,” while section 10 bars any AARTC from operating unlicensed. We have not seen DHI say in writing whether a private-pay residence with no public money falls inside the license. Put that exact question to DHI before you sign for a building.

Levels of Care Under the AARTC License

On the substance use side, 8.321.13.9.A limits the license to adults 18 and older at ASAM level of care three. The levels themselves are spelled out in HCA’s behavioral health services rule, 8.321.2.10 NMAC, and the licensing rule adds a medical floor for the two withdrawal management levels.

ASAM level	Where New Mexico addresses it	What the rule says
3.1	8.321.2.10	At least five hours a week of recovery skills development
3.3	8.321.2.10	Listed as a recognized AARTC level
3.5	8.321.2.10	Listed as a recognized AARTC level
3.7	8.321.2.10	Nursing staff on site 24 hours a day, with a physician or clinical nurse practitioner reachable by phone around the clock
3.2-WM	8.321.13.9.A and 8.321.2.10	24-hour supervision, with stays typically 3 to 5 days
3.7-WM	8.321.13.9.A and 8.321.2.10	24-hour registered nursing care with physician visits, typically no more than seven days

The numbering follows the ASAM Criteria’s third edition, which is why 3.3 and 3.2-WM still appear. We found no New Mexico rule adopting the fourth edition, so in our view policies should be written to the levels exactly as listed.

Where CARF’s ASAM Certification Fits in New Mexico

The accreditation New Mexico asks for is accreditation of the facility as a residential treatment program. CARF also sells a narrower product, the ASAM Level of Care Certification, which CARF says is available “for adult Levels of Care 3.1, 3.5, and 3.7.” ASAM delivers it jointly with CARF and ties the rating elements to its Fourth Edition. Our reading is that it can back up a New Mexico program’s 3.1, 3.5 or 3.7 designation with an outside check, but it doesn’t reach 3.3, and it stops short of withdrawal management. CARF offers it for adult residential 3.1, 3.5 and 3.7 only, so New Mexico’s own 3.2-WM and 3.7-WM levels sit outside it even though 3.7 itself is covered. New Mexico doesn’t require it, and we would not expect it to show on the DHI license. A payer or referral source who wants to confirm it can check CARF’s provider search and tick the matching ASAM Level of Care box under its Certification filter.

Building Standards Written Into 8.321.13

The physical plant sections are unusually specific for a behavioral health rule. A private resident room needs at least 100 square feet of floor area, a semi-private room 80 square feet per resident, rooms are assigned by gender, and shared living, dining and social space has to reach 250 square feet or 40 square feet per resident, whichever is larger (8.321.13.54 and 8.321.13.56). The licensing packet also calls for zoning approval, a certificate of occupancy, fire authority approval, New Mexico Environment Department approvals where they apply and a Board of Pharmacy drug permit (8.321.13.11.B). A newly built facility goes through an initial Life Safety Code survey before DHI issues the license.

Families get a statutory role too. Since May 15, 2024, Section 24A-3-4 has required a residential behavioral health facility to seek family contact information at admission, and the AARTC packet asks for the policy that carries it out. Skipping that step can cost a facility as much as $750 the first time and $1,000 for each later violation.

No Certificate of Need, and Where Hospitals Fit

New Mexico has not run certificate of need review in decades. A 2003 fiscal impact report prepared for the Legislature says “The old certificate of need process was discontinued in 1987,” and we found no CON provision in the current Health Care Code. Bed counts are a matter between you, your zoning office and DHI’s licensing fee schedule.

Medically managed inpatient care belongs to a different license. 8.370.12 NMAC, the hospital rule DHI has administered since July 1, 2024, covers special hospitals, and the fee schedule in 8.370.3 NMAC names special hospitals for alcohol and drug abuse treatment at $12.00 per bed each year. A residence licensed as an AARTC doesn’t take that route.

Medication for Opioid Use Disorder in an AARTC

The licensing rule itself contains no MOUD language. The standard BHSD applies sits in 8.321.2.10, which requires an AARTC to provide medication-assisted treatment for opioid use disorder as indicated, allows it to coordinate with another agency to do so, and states that “an AARTC may not exclude recipients from receiving AARTC services on the basis of receiving MAT services.” Because the license needs BHSD’s approval letter, we’d write that coordination into policy before the first admission.

Methadone dosing belongs to opioid treatment programs, licensed on a separate track under 8.321.10 NMAC (repealed and replaced in Register Vol. XXXVII, Issue 9), so a residence with methadone patients should have a signed coordination agreement with the OTP where they dose. Buprenorphine needs less. The waiver requirement is history, and DEA put it plainly in a registrant letter sent January 12, 2023: “A DATA-Waiver registration is no longer required to treat patients with buprenorphine for opioid use disorder.” On the state side, a New Mexico prescriber also holds a state controlled substance registration from the Board of Pharmacy and registers with the prescription monitoring program (16.19.20.8 NMAC). Watch for one stale line: 8.321.2.28 still refers to the DATA 2000 waiver that no longer exists.

Adding Ketamine to a New Mexico Residential Program

We found no New Mexico rule that mentions ketamine in residential treatment. The prescriber conditions come from a 2023 advisory the Boards of Nursing and Medicine issued together, and what that means for an AARTC license is our interpretation of 8.321.13 and the Board of Pharmacy rules.

8.321.13 doesn’t regulate individual drugs. A license amendment is triggered by a change of administrator or director or a change of facility name (8.321.13.12.B), and putting a resident with co-occurring depression or PTSD on ketamine is neither, so our reading is that the license itself doesn’t change. The program still needs the Board of Pharmacy drug permit that 8.321.13.11.B lists for drug handling, and a new applicant should name ketamine among the services in its letter of intent. An AARTC that is already licensed should, in our view, send DHI and its accreditor a short written notice ahead of any ketamine treatment.

The 2023 Joint Advisory

The New Mexico Medical Board posts the Board of Nursing Advisory: Ketamine, reviewed by the Board of Pharmacy, alongside the Medical Board’s guidance on off-label use of ketamine, issued May 19, 2023. The advisory says “Ketamine must be administered only by a provider that has been trained in its clinical indications, effect monitoring, and outcomes evaluation.” It expects a medically recognized illness diagnosed by a provider with validated expertise, ketamine used as part of a complete ongoing treatment plan, a full history and physical, safety equipment on hand and staff trained in ACLS or BLS. It closes with a warning: “Using ketamine outside these guidelines may subject licensees to investigation.” We found no separate Board of Nursing ruling on RNs giving sub-anesthetic ketamine, so the advisory and the program’s own protocol set the nurse’s role.

Registrations and Prescription Monitoring

New Mexico lists “Ketamine Hydrochloride” in Schedule III (16.19.20 NMAC). The prescriber needs DEA registration and a state controlled substance registration, and 16.19.20.8 also requires clinics to register with the Board of Pharmacy. A certified nurse practitioner can carry this prescribing alone in New Mexico. Under 16.12.17 NMAC, effective January 1, 2026, “The CNP makes independent decisions regarding the health care needs of the client,” and a CNP can prescribe Schedules II through V after 400 hours of prescribing experience, provided both registrations are current.

Prescription monitoring is where the documents disagree. The joint advisory says ketamine use is required to be reported in the Prescription Monitoring Program, but the Board of Pharmacy’s PMP rule (16.19.29 NMAC) says a dispenser does not include “a practitioner, or other authorized person who administers such a substance.” Our reading is that doses given on the unit fall outside the rule’s reporting duty and take-home prescriptions don’t, and we’d ask the Board of Pharmacy to confirm before relying on that. Spravato adds federal conditions on top. Under its FDA label, only a REMS-certified healthcare setting may use it, with monitoring “for at least 2 hours after administration of SPRAVATO.”

Which Residents Are Candidates

No FDA approval covers ketamine as an addiction treatment. The Ketalar label lists only anesthesia uses, so ketamine is not MOUD and can’t stand in for the MAT access 8.321.2.10 expects. In our view a resident becomes a candidate only once detox is behind them and they have had time to settle in, and only if mood or trauma symptoms are still blocking progress after the usual treatments have been tried. A history of misusing ketamine or other dissociatives is a strong reason to look elsewhere, and the actual screening criteria are the program physician’s call.

Finishing the Series After Discharge

A ketamine series can outlast a residential stay, and when it does the later sessions move to an outpatient practice. Corporate practice is not a barrier here. Attorney General Opinion 87-39 (July 30, 1987) answered “Yes, unless prohibited by statute” when asked whether a corporation controlled by non-physicians could provide medical services through employed physicians, and the 2025 Corporate Practice of Medicine Act (SB 450) died without passing. A lay-owned company can therefore employ the physicians as long as it stays out of their medical judgment, a limit the opinion spells out, though we’d still keep clinical decisions with a physician or CNP practice and put the lease, staff and billing in a management company. The outpatient structure is set out in the ketamine section of New Mexico Drug and Alcohol Outpatient Treatment Licensing.

Referrals between the residence and that clinic need a lawyer’s look first. 18 U.S.C. 220 defines a clinical treatment facility as “a medical setting, other than a hospital, that provides detoxification, risk reduction, outpatient treatment and care, residential treatment, or rehabilitation for substance use, pursuant to licensure or certification under State law.” An AARTC licensed for substance use care now fits that wording, and for services a health care benefit program covers, the statute’s penalties reach $200,000 in fines and 10 years in prison “for each occurrence.” In our reading an AARTC serving only the mental health track would fall outside the definition, though we would not pay or accept referral fees either way. Our search turned up no New Mexico patient brokering statute.

Staffing an AARTC

8.321.13 has no staffing section. Apart from the 24-hour supervision at 3.2-WM and the round-the-clock RN care at 3.7-WM, it sends operators to BHSD: “All AARTC’s licensed pursuant to these regulations must have written policies and procedures in accordance with the standards set forth by BHSD.” BHSD’s AARTC rule in 8.321.2.10 calls for treatment directed by an independently licensed clinician, staff available 24 hours to respond to crises, ASAM training for every licensed practitioner, background checks every three years, and nursing on site at all hours at 3.7.

Counselor pay here runs well ahead of the country. For substance abuse, behavioral disorder, and mental health counselors, the BLS median in New Mexico is $74,100 (OEWS, May 2025). The 25th percentile sits at $60,300 and the 75th at $89,800, against a national median of $59,350. A clinical director plus five counselors at the state median comes to about $444,600 a year (6 x $74,100, our estimate) without counting nurses, overnight staff, administration and benefits. That number assumes a fully licensed clinical team, and New Mexico’s counselor ladder lets a residence open well short of one. The Counseling and Therapy Practice Board licenses the Licensed Substance Abuse Associate (LSAA) with an associate degree and 90 clock hours of substance abuse training, and an LSAA “must practice under supervision at all times” (16.27.13 NMAC). The step above is the LADAC, an independent license that a master’s-level candidate reaches after one year, 1,000 supervised client contact hours and 50 hours of supervision (16.27.11 NMAC). An independently licensed clinical director who supervises associates earning those hours, at associate pay, typically brings clinical payroll in 40 to 60 percent under what an all-licensed roster would cost. Outside 3.7-WM, where registered nursing is required at every hour, one RN overseeing several LPNs keeps nursing costs down as well. Bed count and the levels you’re approved for set the final numbers.

Accreditation Is the Entry Ticket

For an AARTC, accreditation decides when the license can issue. An existing facility is licensed “Upon approval of the accrediting organization,” and a new one needs that approval plus an initial Life Safety Code survey (8.321.13.11.C and D). BHSD’s own program overview asks for accreditation by COA, the Joint Commission or CARF as a residential treatment facility before an applicant even applies for BHSD’s letter. The renewal section doesn’t mention accreditation, but in our reading a program that loses it would struggle to keep BHSD’s approval, which the license was built on.

The hard part for a new building is sequence. The accreditor wants to see a program it can survey, and DHI wants the accreditor’s letter before licensing. We’d raise the timing with DHI and the accreditor together at the start rather than discover the circle halfway through, and we plan around roughly 9 to 15 months from lease to license for a new residence. That range is our estimate, not a state figure.

How to Submit Your New Mexico AARTC Application

HCA’s facility licensing page and 8.321.13.11 set the order:

1. Earn accreditation as an adult residential treatment facility from the Joint Commission, CARF or COA.
2. Apply to BHSD for its AARTC approval. The program overview directs initial applications to nmrecovery.org and lists aartc@nmrecovery.org for questions. BHSD issues a provisional first year, then a two-year certification after its site visit.
3. Email a letter of intent on letterhead to facility.license@hca.nm.gov with the fifteen items in 8.321.13.11.A, including the number of residential beds, the list of services and both approval letters. DHI emails the application packet once the letter is approved.
4. Send plans for a new or remodeled building to the Program Operations Bureau (505-476-9093) before construction, and get Board of Pharmacy approval for drug handling (505-841-9102).
5. Mail the completed application with the non-refundable fee, zoning approval, certificate of occupancy, fire approval, any NMED approvals, the drug permit and the family notification policy to DHI at P.O. Box H, Santa Fe, NM 87504.

The fee schedule, as amended effective September 1, 2026 (8.370.3.10), lists the AARTC at $600.00 “bi-annually” plus $25 per bed. Since the license runs two years (8.321.13.12.A), our reading is $600 per license term plus the bed charge, so a 16-bed residence would pay $1,000 by our arithmetic. Confirm the figure with DHI, because the statute in 24A-1-5 still describes one-year licenses. Renewal goes in at least 30 days before expiration, a change of administrator or facility name needs an amended license within 10 working days, and a license that lapses means the facility “shall cease operations until it obtains a new license through the initial licensure procedures” (8.321.13.13). Medicaid enrollment with HCA’s Medical Assistance Division is a separate matter from the license, and not one we take on.

Where New Mexico Residential Files Stall

From what we’ve seen of new licensing rules, the first delay is usually the accreditation and BHSD letters arriving later than the lease payments start. Close behind is a policy manual written to an accreditor’s standards with no crosswalk to BHSD’s, even though 8.321.13.23 ties AARTC policies to BHSD. Forms or letterhead that still address the Department of Health draw questions, and so does a packet missing the 24A-3-4 family notification policy, which is easy to forget because it comes from a statute rather than the licensing rule.

Frequently Asked Questions

Lining up accreditation and a DHI license for the same New Mexico residence? Tell us where you are in the process.

Sources

• HCA, Division of Health Improvement: Health Facility Licensing and Certification (checked October 19, 2026)
• HCA, Division of Health Improvement: Facility licensing application steps (checked October 19, 2026)
• HCA, About the Department: Health Care Authority launch, July 1, 2024 (checked October 19, 2026)
• 8.321.13 NMAC, New Mexico Register: Requirements for Adult Accredited Residential Treatment Center (eff. May 19, 2026) (checked October 19, 2026)
• 8.321.13 NMAC, HCA copy: Adult Accredited Residential Treatment Center rule (PDF) (checked October 19, 2026)
• New Mexico Register Vol. XXXVII, Issue 10: Adopted rules, May 19, 2026 (checked October 19, 2026)
• New Mexico Legislature, LHHS Committee, October 6, 2025, Item 12: Handout on residential treatment gaps (PDF) (checked October 19, 2026)
• New Mexico Legislature, 2024 SB 14: Health Care Authority, bill status (Laws 2024, ch. 39) (checked October 19, 2026)
• NMSA 1978, Chapter 24A, Sections 24A-1-5 and 24A-3-4 (NM Compilation Commission): Health Care Code (checked October 19, 2026)
• 8.321.2 NMAC, Sections 10 and 28: Behavioral health services (PDF) (checked October 19, 2026)
• HCA, BHSD: Appendix I, Behavioral Health Specialty Program Overview (PDF) (checked October 19, 2026)
• 8.370.3 NMAC, Section 10, as amended: Health facility license fees, eff. September 1, 2026 (checked October 19, 2026)
• 8.370.3 NMAC: Health facility license fees (PDF) (checked October 19, 2026)
• 8.370.12 NMAC: Requirements for Acute Care, Limited Services and Special Hospitals (PDF) (checked October 19, 2026)
• New Mexico Legislature, 2003 HB 802: Fiscal impact report on certificate of need (checked October 19, 2026)
• New Mexico Register Vol. XXXVII, Issue 9: Adopted rules, 8.321.10 NMAC Opioid Treatment Programs (checked October 19, 2026)
• DEA Diversion Control Division: Dear Registrant letter, January 12, 2023 (PDF) (checked October 19, 2026)
• 16.19.20 NMAC: Controlled substances, Schedule III and registration (PDF) (checked October 19, 2026)
• 16.19.29 NMAC: Prescription monitoring program (PDF) (checked October 19, 2026)
• New Mexico Medical Board: Board of Nursing Advisory: Ketamine (PDF) (checked October 19, 2026)
• New Mexico Medical Board: Off-label use of ketamine, May 19, 2023 (PDF) (checked October 19, 2026)
• 16.12.17 NMAC, New Mexico Register: Advanced practice registered nurses (eff. January 1, 2026) (checked October 19, 2026)
• U.S. FDA: SPRAVATO prescribing information, REMS and monitoring (PDF) (checked October 19, 2026)
• U.S. FDA: KETALAR (ketamine) prescribing information, indications (PDF) (checked October 19, 2026)
• New Mexico Attorney General: Opinion 87-39, corporate employment of physicians (checked October 19, 2026)
• New Mexico Legislature, 2025 SB 450: Corporate Practice of Medicine Act, bill status (checked October 19, 2026)
• 18 U.S.C. 220, via Cornell LII: Illegal remunerations for referrals to recovery homes, clinical treatment facilities, and laboratories (checked October 19, 2026)
• 16.27.11 NMAC: Licensed Alcohol and Drug Abuse Counselor (PDF) (checked October 19, 2026)
• 16.27.11 NMAC amendment, New Mexico Register: LADAC amendment, November 18, 2025 (checked October 19, 2026)
• 16.27.13 NMAC: Licensed Substance Abuse Associate (PDF) (checked October 19, 2026)
• 16.27.13 NMAC amendment, New Mexico Register: LSAA amendment, November 18, 2025 (checked October 19, 2026)
• U.S. Bureau of Labor Statistics, OEWS May 2025, SOC 21-1018: New Mexico estimates (checked October 19, 2026)
• U.S. Bureau of Labor Statistics, OEWS May 2025, SOC 21-1018: National estimates (checked October 19, 2026)
• CARF: ASAM Level of Care Certification (checked October 19, 2026)
• ASAM: Level of Care Certification (checked October 19, 2026)
• CARF: Find a Provider (Certification filter) (checked October 19, 2026)